Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3992270 | Journal of Thoracic Oncology | 2009 | 4 Pages |
Abstract
Dysregulation of mesenchymal-epithelial transition factor receptor tyrosine kinase pathway leads to cell proliferation, protection from apoptosis, angiogenesis, invasion, and metastasis. It can be dysregulated through overexpression, constitutive activation, gene amplification, ligand-dependent activation or mutation. New drugs targeting various mesenchymal-epithelial transition factor pathways are being investigated with promising results.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Eric S. Kim, Ravi Salgia,